; and (2) the status of the guidance documents that the Secretary intends to issue with respect to reporting and risk management plan requirements applicable to manufacturers of drugs and active pharmaceutical ingredients, pursuant to the amendments made to section 506C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 356c ) by subsections (a) and (b) of section 3112 of the Coronavirus Aid, Relief, and Economic Security Act ( Public Law 116–136 ). VI Additional reauthorizations and technical amendments 601. Medical countermeasure priority review voucher Section 565A(g) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–4a ) is amended by striking 2023 and inserting 2028 . 602. Epidemic Intelligence Service loan repayment program Section 317F(c)(2) of the Public Health Service Act ( 42 U.S.C. 247b–7(c)(2) ) is amended by striking 2019 through 2023 and inserting 2024 through 2028 . 603. Vaccine tracking and distribution Section 319A(e) of the Public Health Service Act ( 42 U.S.C. 247d–1(e) ) is amended by striking 2019 through 2023 and inserting 2024 through 2028 . 604. Regional health care emergency preparedness and response systems Section 319C–3(e)(2) of the Public Health Service Act (42 U.S.C. 247d–3c(e)(2)) is amended by striking 2023 and inserting 2028 . 605. Emergency system for advance registration of volunteer health professional Section 319I(k) of the Public Health Service Act (42 U.S.C. 247d–7b(k)) is amended by striking 2019 through 2023 and inserting 2024 through 2028 . 606. Limited antitrust exemption Section 319L–1(b) of the Public Health Service Act (42 U.S.C. 247d–7f(b)) is amended by striking at the end of the 17-year period that begins on the date of enactment of this Act and inserting on September 30, 2028 . 607. Trauma care Section 1232(a) of the Public Health Service Act ( 42 U.S.C. 300d–32(a) ) is amended by striking $24,000,000 for each of fiscal years 2023 through 2027 and inserting $39,000,000 for each of fiscal years 2024 through 2028 . 608. Military and civilian